We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Low Cost Portable Genomic Sequencing Platform to Help Labs in Developing Countries Track SARS-CoV-2 Variants

By LabMedica International staff writers
Posted on 02 Sep 2021
Print article
Image: Portable genomics device (Photo courtesy of Michael Bacus)
Image: Portable genomics device (Photo courtesy of Michael Bacus)
An international volunteer team of scientists has brought a portable sequencing platform for SARS-CoV-2 monitoring to developing countries.

Scientists at the Philippine Genome Center Mindanao (Davao, Philippines) and the University of Amsterdam (Amsterdam, Netherlands) have partnered with Accessible Genomics, a group of volunteering scientists from all around the world to implement a low start-up cost genomic sequencing platform for laboratories in developing countries. Genomic data can be used to identify and track variants of the virus, which helps scientists and government officials make better decisions about quarantine measures and vaccine administration. However, not all countries have access to the equipment, chemicals, and know-how to perform enough genomic sequencing to sufficiently track SARS-CoV-2 variants. Genomic sequencing is rare in low-income countries and prevents local governments and hospitals to make better-informed decisions to lower infections and deaths.

A group of students and scientists from the field of portable genomics who have formed Accessible Genomics piloted SARS-CoV-2 sequencing in a representative lab from the Philippines which has complementary skills, facility, and experience on next generation sequencing, using recent advances in portable genomics technology. This partnership will serve as a learning experience for the local centre as it prepares to expand its omics facility and services in the region. Currently, plans are underway to fast-track the expansion of genomic surveillance in the main regions of the country through the Department of Health and Department of Science and Technology, as well as other efforts by both the government and private sectors in the country. The next step of the project is to replicate the initiative in other countries and help labs in other developing countries to get started in variant identification.

“Like many developing countries, genomic sequencing machines in the Philippines were all housed in labs in the capital, Metro Manila. This was because sequencing machines used to cost more than a car and were as large as refrigerators”, said Ineke Knot from the Institute for Biodiversity and Ecosystem Dynamics (IBED) at the University of Amsterdam. “Portable genomic sequencing was made possible in the past few years due to innovations like the MinION sequencer by Oxford Nanopore Technologies. This sequencing machine costs less than an iPhone and is as small as one too.”

Related Links:
Philippine Genome Center Mindanao
University of Amsterdam


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
COVID-19 Rapid Test
AQ+ COVID-19 Ag Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.